Resonance Health Limited (ASX:RHT)

Australia flag Australia · Delayed Price · Currency is AUD
0.0440
+0.0040 (10.00%)
At close: Jan 22, 2026
-16.98%
Market Cap20.89M
Revenue (ttm)11.07M
Net Income (ttm)-1.73M
Shares Out474.79M
EPS (ttm)-0.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume567,426
Average Volume245,539
Open0.0410
Previous Close0.0400
Day's Range0.0410 - 0.0450
52-Week Range0.0330 - 0.0660
Beta1.21
RSI46.97
Earnings DateFeb 26, 2026

About Resonance Health

Resonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices (SaMD) in the Asia Pacific, North America, Europe, the Middle East, and Africa. It operates through SaMD, Resonance Clinical, and TrialsWest segments. The company offers FerriScan, a non-invasive MRI based solution for quantifying liver iron concentration (LIC); FerriSmart, an artificial intelligence (AI) solution for the automated real-time assessment of LIC; HepaFatScan, a non-invasive MRI-bas... [Read more]

Sector Healthcare
Founded 1987
Employees 16
Stock Exchange Australian Securities Exchange
Ticker Symbol RHT
Full Company Profile

Financial Performance

Financial Statements